TECHNOLOGY
Outrage grows as CDC reportedly poised to fund "unethical" vaccine trial
Ars TechnicaFriday, October 9, 2026 at 7:27 PM
RedScroll Brief
6M for study on alleged harms of hepatitis B vaccine.
RedScroll Signal
- Impact
- High
- Category
- Technology
- Market relevance
- Moderate
- Why it matters
- Technology shifts change how people work, communicate, and build — often faster than policy can follow. 6M for study on alleged harms of hepatitis B vaccine. Secondary effects may show up in markets and supply chains linked to Outrage and Technology.
Desk copy
RedScroll Briefing
Extractive editorial brief — not a reprint of the original
What happened
6M for study on alleged harms of hepatitis B vaccine.
Why it matters
Technology shifts change how people work, communicate, and build — often faster than policy can follow.
Background
Ars Technica reported on this under technology. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.
Timeline
Ars Technica published: Outrage grows as CDC reportedly poised to fund "unethical" vaccine trial
Story is in today’s RedScroll edition. Follow the original source for updates.
Economic impact
Secondary effects may show up in markets and supply chains linked to Outrage and Technology.
More on
Related stories
- The Download: AI’s refusal problem and weight-loss drug side effects
MIT Technology ReviewTECHNOLOGY
- The Download: AI roadblocks for humanoids and portable rubber dams
MIT Technology ReviewTECHNOLOGY
- The Download: weight-loss drugs slowing aging and carbon dioxide batteries
MIT Technology ReviewTECHNOLOGY
- AI coding agents generate more code, but not more software
Ars TechnicaTECHNOLOGY
- PC shipments fall 20.1 percent in “sharpest decline” since Q1 2023
Ars TechnicaTECHNOLOGY
- Rocket Report: A rare Falcon 9 scrub; is it just about Vulcan's time to shine?
Ars TechnicaTECHNOLOGY
Source
Ars Technica
Original reporting by Ars Technica. RedScroll provides an extractive briefing only.